Advertisement

  • Finding More Targets for CAR-T Cells

    CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.

    by Kendall K. Morgan

  • Survivor Profile

    Still in the Game

    ESPN reporter Holly Rowe worked through melanoma treatment.

    by Lindsey Konkel

  • More Options for Rare Cancers

    Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.

    by Kendall K. Morgan

  • An Uncommon Partnership

    Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.

    by Ashley P. Taylor

  • Learning to Share

    At first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was.

    by Lenn Robbins

  • Brain Cancer Patients Make Connections

    An app developed for glioblastoma patients allows them to track their symptoms and contribute to research.

    by Brad Jones

  • Survivor Profile

    A Second Chance

    After the deaths of her sister and mother from cancer and a bout with osteosarcoma as a teenager, Court Simmons vowed to “do something amazing” with her life. Her goal is to be a pediatric oncology nurse.

    by Lindsey Konkel

  • Q&A

    A Rare Drive

    Chordoma survivor Josh Sommer brings together researchers and patients to develop better treatments for an uncommon cancer.

    by Kate Yandell

  • Survivor Profile

    Betting on Science

    Diagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.

    by Betty Russell

  • Forward Look

    Orphan Drugs Still Find a Home

    Thirty years on, landmark federal legislation continues to benefit patients with rare cancers.

    by Emily Gertz

Advertisement
Advertisement

From the AACR

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR